The Future, page-2

First 2 Last

Share
Profile

Follow
anthony09

133 Posts.

18

09/02/17

19:38

Post #: 22498844
Share

Originally posted by bakery ↑

I have asked Chris for permission to post his reply which he has agreed:

Our CFO passed me your email for response.

I am very sorry to hear that you have lost a large proportion of the value of your investment. I believe that my predecessor was likely correct in saying that Karara had been hit by a perfect storm.

I would note that Gindalbie has retained Karara at a nil value on our books since 2014, our changes in the quarterly were made following review of our communications to better highlight the status of the asset to our shareholders. We feel it is important, especially in the current iron ore price environment to be clear about the value of the asset.

We do regularly review the holding value of our investment in Karara and the asset remains at a nil value based on our models and scenario analysis. The reality is that Karara is carrying very high levels of debt and that it would take a very prolonged increase in the iron ore price in excess of current forecasts for that situation to change.

Gindalbie’s primary focus and potential for future shareholder value growth lies in our business development plans and future projects. Gindalbie is in a very strong cash position and has significantly reduced our administration costs which leaves us in a relatively rare position in the market. As we mention in our annual report, our intention is to capitalise on this platform and to build growth for our shareholders. We do hope to be able to make an announcement at the appropriate time.

I thank you for your continued support of Gindalbie and on a personal note I can tell you that our very small team is passionate and dedicated to moving the company forward.

Kind regards,

Chris Stevens
Chief Executive Officer

Expand

Great post. It raises the question, what are we invested in now? The tone of the reference to Karara is very concerning. I thought there was light at the end of the tunnel, but it reads as though there is not. Is there a tone of confidence about what GBG is moving into? Or are they just dwindling the funds in administration costs?

GBG Price at posting: 2.9¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

PYC

Scientific conference spotlights PYC's work on blindness disease treatment

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

DUI

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

HotCopper Highlights: Your most watched stocks for Week 47, 2024

SIG

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

LPE

Sales growth pushes Lovisa's fortunes (and shares) upwards

There are more pages in this discussion • 18 more messages in this thread...

First 2 Last

Add GBG (ASX) to my watchlist

The Future, page-2

Top Stories

Scientific conference spotlights PYC's work on blindness disease treatment

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M

HotCopper Highlights: Your most watched stocks for Week 47, 2024

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

Sales growth pushes Lovisa's fortunes (and shares) upwards

Featured News